Literature DB >> 12441942

Prevalence of prostatitis-like symptoms in a community based cohort of older men.

Rosebud O Roberts1, Debra J Jacobson, Cynthia J Girman, Thomas Rhodes, Michael M Lieber, Steven J Jacobsen.   

Abstract

PURPOSE: We describe a community based study to estimate the prevalence of prostatitis-like symptoms using questions similar to the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).
MATERIALS AND METHODS: Study subjects were a randomly selected sample of Olmsted County, Minnesota white men 40 to 79 years old in January 1990 who participated in a longitudinal study of lower urinary tract symptoms. Subjects were evaluated biennially using self-administered questionnaires. In 2000 questions similar to the NIH-CPSI were incorporated into the questionnaire and questionnaire responses were used to categorize men as having prostatitis-like symptoms.
RESULTS: Of 1,541 men 182 (12%) had at least 1 urogenital pain symptom. Pubic (76 men, 4.9%) and testicular (73, 4.7%) pain were the most frequent pain symptoms. A total of 34 men with prostatitis-like symptoms (2.2%) had higher mean pain (6.7 versus 0.5), urinary symptom (3.5 versus 2.1) and quality of life impact (3.7 versus 1.9) scores compared to men who did not (all p <0.001). Pain frequency (OR 39.2, 95% CI 18.8, 81.9) and pain intensity (OR 21.5, 95% CI 8.7, 52.9) were more strongly associated with prostatitis-like symptoms than urinary symptom score (OR 2.8, 95% CI 1.4, 5.6) or quality of life impact score (OR 4.5, 95% CI 1.9, 10.7).
CONCLUSIONS: Although urogenital pain is common among community dwelling men, prostatitis-like symptoms based on the modified questions from the NIH-CPSI are less common. While pain measures may be useful in distinguishing between men with and without prostatitis-like symptoms, the urinary symptom and quality of life impact scores could partly reflect benign prostatic hyperplasia.

Entities:  

Mesh:

Year:  2002        PMID: 12441942     DOI: 10.1097/01.ju.0000036433.07079.ce

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

Review 1.  Epidemiology of prostatitis: new evidence for a world-wide problem.

Authors:  John N Krieger; Donald E Riley; Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen
Journal:  World J Urol       Date:  2003-04-24       Impact factor: 4.226

Review 2.  Functional and chronic anorectal and pelvic pain disorders.

Authors:  Adil E Bharucha; Emanuel Trabuco
Journal:  Gastroenterol Clin North Am       Date:  2008-09       Impact factor: 3.806

Review 3.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

4.  Alpha-blockers for the treatment of prostatitis-like syndromes.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2006

5.  The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey.

Authors:  Jim C Hu; Carol L Link; Mary McNaughton-Collins; Michael J Barry; John B McKinlay
Journal:  J Gen Intern Med       Date:  2007-09-01       Impact factor: 5.128

Review 6.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

8.  α-Blockers for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Update on Current Clinical Evidence.

Authors:  J Curtis Nickel; Naji Touma
Journal:  Rev Urol       Date:  2012

Review 9.  Epidemiology of prostatitis.

Authors:  John N Krieger; Shaun Wen Huey Lee; Jeonseong Jeon; Phaik Yeong Cheah; Men Long Liong; Donald E Riley
Journal:  Int J Antimicrob Agents       Date:  2007-12-31       Impact factor: 5.283

10.  Antibiotic and anti-inflammatory use and the risk of prostate cancer.

Authors:  Nicholas A Daniels; Yea-Hung Chen; Stephen Bent
Journal:  BMC Res Notes       Date:  2009-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.